Experts seek painkiller ban

Last updated 05:00 14/02/2013

Relevant offers

Health

Injuries on school grounds cost millions each year MidCentral health workers' strike may delay cancer treatment Calls for parliamentary inquiry into use of surgical mesh Lecretia Seales: Wait for decision begins Hawke's Bay DHB becomes first to decline national food contract Parental notification not a black-and-white issue Latoiya is battling brain tumour Cohen syndrome not holding Southland youngster back Govt names new providers to replace Relationships Aotearoa Manawatu nurses reject district health board pay offer

A popular painkiller should be banned worldwide because it raises the risk of heart attack and stroke by almost half, British academics say.

Risks from diclofenac, widely sold as Voltaren, were highest in those who used it regularly, and safer options were available, they said.

Medsafe in New Zealand said it would consider the research, but noted previous reviews had shown its benefits outweighed potential risks.

Diclofenac is a non-steroidal anti-inflammatory drug often prescribed after surgery or to combat arthritic pain when other painkillers are not strong enough.

It has been available in New Zealand for more than 20 years. I

t is subsidised by state drug-buying agency Pharmac, with 375,000 people being prescribed it in the year ending November 2012. That figure does not include those who buy it over the counter.

Ad Feedback

- The Dominion Post

Special offers
Opinion poll

Should fluoride in water be the responsibility of central government?

Yes

No

Vote Result

Featured Promotions

Sponsored Content